Header Logo

Sheila Dowd

Concepts (78)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Phobia, Social
4
2023
12
0.760
 Why?
Cycloserine
5
2023
25
0.720
 Why?
Implosive Therapy
4
2023
16
0.620
 Why?
Transcranial Magnetic Stimulation
6
2015
15
0.410
 Why?
Depressive Disorder, Major
4
2015
97
0.350
 Why?
Antimetabolites
3
2019
14
0.330
 Why?
Clonazepam
3
2003
26
0.310
 Why?
Treatment Outcome
10
2023
3391
0.220
 Why?
Flunitrazepam
1
2002
1
0.210
 Why?
Substance Abuse Treatment Centers
1
2002
2
0.210
 Why?
GABA Modulators
1
2002
4
0.210
 Why?
Rape
1
2002
5
0.210
 Why?
Anti-Anxiety Agents
1
2002
37
0.200
 Why?
Antibiotics, Antitubercular
1
2020
2
0.180
 Why?
Adult
12
2021
7448
0.150
 Why?
Antidepressive Agents
2
2015
93
0.150
 Why?
Extinction, Psychological
3
2023
12
0.150
 Why?
Electroconvulsive Therapy
3
2007
16
0.140
 Why?
Double-Blind Method
4
2020
400
0.130
 Why?
Depressive Disorder, Treatment-Resistant
1
2015
9
0.130
 Why?
Panic Disorder
1
2016
129
0.130
 Why?
Humans
16
2023
26286
0.110
 Why?
Depressive Disorder
2
2007
167
0.110
 Why?
Combined Modality Therapy
3
2023
281
0.110
 Why?
Phobic Disorders
1
2013
64
0.110
 Why?
Behavior Therapy
1
2013
81
0.100
 Why?
Sleep Wake Disorders
1
2013
102
0.100
 Why?
Fear
2
2023
43
0.100
 Why?
Anxiety Disorders
2
2023
157
0.100
 Why?
Female
11
2020
14539
0.100
 Why?
Male
10
2020
14162
0.090
 Why?
Middle Aged
9
2016
8601
0.080
 Why?
Psychiatric Status Rating Scales
4
2013
303
0.070
 Why?
Placebos
2
2020
66
0.070
 Why?
Anticonvulsants
2
2007
56
0.070
 Why?
Attention
2
2003
126
0.060
 Why?
Substance Abuse Detection
1
2003
5
0.060
 Why?
Severity of Illness Index
2
2020
936
0.050
 Why?
Electric Stimulation
1
2003
59
0.050
 Why?
Forensic Medicine
1
2002
1
0.050
 Why?
Hair
1
2002
3
0.050
 Why?
Anxiety
1
2023
136
0.050
 Why?
Pilot Projects
2
2015
378
0.050
 Why?
Recurrence
2
2015
314
0.050
 Why?
Memory
1
2002
299
0.050
 Why?
Cognition Disorders
2
2007
984
0.040
 Why?
Drug Administration Schedule
1
2020
156
0.040
 Why?
Young Adult
2
2016
1886
0.040
 Why?
Galvanic Skin Response
1
2019
6
0.040
 Why?
Photic Stimulation
1
2019
32
0.040
 Why?
Placebo Effect
1
2019
19
0.040
 Why?
Mental Recall
1
2019
67
0.040
 Why?
Case-Control Studies
1
2020
566
0.040
 Why?
Prospective Studies
2
2015
1668
0.040
 Why?
Time Factors
2
2015
1391
0.030
 Why?
Retreatment
1
2015
8
0.030
 Why?
Watchful Waiting
1
2015
9
0.030
 Why?
Drug Resistance
1
2015
42
0.030
 Why?
Feasibility Studies
1
2015
210
0.030
 Why?
Gas Chromatography-Mass Spectrometry
2
2003
13
0.030
 Why?
Predictive Value of Tests
1
2013
460
0.020
 Why?
Comorbidity
1
2013
475
0.020
 Why?
Adolescent
2
2011
2080
0.020
 Why?
Kaplan-Meier Estimate
1
2010
162
0.020
 Why?
Aged
2
2015
8765
0.020
 Why?
Clinical Trials as Topic
1
2007
215
0.020
 Why?
Research Design
1
2007
183
0.020
 Why?
Follow-Up Studies
1
2010
1738
0.020
 Why?
Age Factors
1
2007
753
0.020
 Why?
Calibration
1
2003
19
0.010
 Why?
Reference Standards
1
2003
23
0.010
 Why?
Reaction Time
1
2003
109
0.010
 Why?
Memory, Short-Term
1
2003
99
0.010
 Why?
Electromagnetic Fields
1
2002
8
0.010
 Why?
Psychomotor Performance
1
2003
202
0.010
 Why?
Sensitivity and Specificity
1
2003
485
0.010
 Why?
Motor Activity
1
2003
315
0.010
 Why?
Neuropsychological Tests
1
2003
1223
0.010
 Why?
Dowd's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (78)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_